/
Our Company CareTrust REIT is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, senior housing and other healthcare-related properties. As of December 31, 2025, CareTrust REIT owned, directly or indirectly in consolidated joint ventures, and leased to independent operators, 407 skilled nursing facilities (each…
$42.88
+$0.91 (+2.17%)
EOD Jul 17, 2026
56.66% operating margin is above average. ROIC at 6.43%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue up 63.5% YoY with margins expanding 17.8pp.
At 27x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
27.1x earnings, 23.3x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$523M
▲ +63.5% YoY
Net Income (TTM)
$335M
▲ +156.3% YoY
Op. Margin
55.81%
▲ +17.8pp YoY
ROIC
5.89%
▲ +3.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$413M
▲ +61.3% YoY
Op. Cash Flow (TTM)
$413M
▲ +61.3% YoY
Net Debt
$671M
Cash & Equiv.
$223M
5Y CAGR: +21.7%
5Y CAGR: +22.0%
Continue Research
At a P/E of 27.1 and a price-to-free-cash-flow of 23.3, CareTrust REIT (CTRE) trades below a two-stage DCF intrinsic value of about $90.09 per share, so at $42.88 the stock looks undervalued (110.1% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, CareTrust REIT scores 85/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.9%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $90.09 per share for CTRE, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $67.57. At today's $42.88, that puts the stock about 110.1% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
CareTrust REIT scores 85 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. Recent fundamentals include a 55.8% operating margin and a 5.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, CareTrust REIT pays a regular dividend of about $1.25 per share per year (typically in quarterly installments), a yield of roughly 2.9% at the current price. That is a payout ratio of about 83.5% of earnings, so the dividend is covered, with less cushion. CareTrust REIT has grown the dividend at roughly 26.7% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For CTRE's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. CTRE currently trades below its estimated intrinsic value and scores 85/100 on quality (high-quality). It also yields about 2.9%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.